This Saturday marks the beginning of the second annual open enrollment period for subsidized health insurance plans administered through the Affordable Care Act exchanges. The American Action Forum has examined the same segment of the market in all areas for which data is accessible—461 out of the 501 rating areas nationwide, covering 43 states. Overall, we find that the benchmark premiums have increased by an average of 3.8 percent nationwide.
Dual Eligibles are individuals qualified to receive both Medicare and Medicaid benefits. Medicare is always the first payer of the two, and Medicaid is used for supplemental coverage, premium and cost-sharing assistance, and payment for services not covered by Medicare.
Health care spending varies widely across the United States and in ways that are not entirely understood.
After accounting for exemptions, AAF estimates that 5.2 million people will be subject to the individual mandate penalty for being uninsured in 2014 and will pay a total of $5.8 billion in additional taxes.
The aging American population is a widely recognized phenomenon that has serious implications for the national economy.
Recently, the Department of Health and Human Services (HHS) released total Health Insurance Marketplace enrollment by zip code for states using the federal exchange.
The Children’s Health Insurance Program (CHIP) was designed in 1997 to provide health insurance to children whose family income exceeded Medicaid eligibility, but was insufficent to purchase private coverage. However, with the implementation of the Affordable Care Act (ACA), many families no longer need CHIP. With funding set to expire next year, the question becomes: who still needs CHIP?
Since its implementation, the Medicare Prescription Drug Program—known as Part D—has cost the federal government less and saved beneficiaries more than expected.
On Tuesday, the Office of the Inspector General (OIG) released an overview of sixty contracts involved in the development and operation of the Federal Health Insurance Marketplace, which began with spectacular failure last fall.
The story of slow health care spending growth is best told as a series of vignettes, one of which features prescription drug innovation.